A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex

The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) emergence in 2003 introduced the first serious human coronavirus pathogen to an unprepared world. To control emerging viruses, existing successful anti(retro)viral therapies can inspire antiviral strategies, as conserved viral enzymes (eg....

Descripción completa

Detalles Bibliográficos
Autores principales: Eydoux, Cecilia, Fattorini, Veronique, Shannon, Ashleigh, Le, Thi-Tuyet-Nhung, Didier, Bruno, Canard, Bruno, Guillemot, Jean-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833800/
https://www.ncbi.nlm.nih.gov/pubmed/33166547
http://dx.doi.org/10.1016/j.jviromet.2020.114013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833800/
https://www.ncbi.nlm.nih.gov/pubmed/33166547
http://dx.doi.org/10.1016/j.jviromet.2020.114013

Ejemplares similares